Heerspink, H. J. L., Stefansson, B. V., Chertow, G. M., Correa-Rotter, R., Greene, T., Hou, F., . . . Wheeler, D. C. (2020). Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial. Nephrol Dial Transplant.
Stile di citazione ChicagoHeerspink, Hiddo J L., et al. "Rationale and Protocol of the Dapagliflozin And Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) Randomized Controlled Trial." Nephrol Dial Transplant 2020.
Citazione MLAHeerspink, Hiddo J L., et al. "Rationale and Protocol of the Dapagliflozin And Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) Randomized Controlled Trial." Nephrol Dial Transplant 2020.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.